Gagnon Securities’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.74M Sell
1,535,812
-326,039
-18% -$1.6M 1.88% 22
2026
Q1
$6.37M Buy
1,861,851
+728,603
+64% +$2.46M 1.47% 23
2025
Q4
$3.21M Sell
1,133,248
-621,585
-35% -$3.21M 0.65% 38
2025
Q3
$12.2M Sell
1,754,833
-144,275
-8% -$1.02M 2.45% 16
2025
Q2
$11.2M Buy
+1,899,108
New +$10.9M 2.28% 17
2018
Q4
Sell
-39,240
Closed -$179K 96
2018
Q3
$179K Sell
39,240
-109
-0.3% -$531 0.04% 96
2018
Q2
$193K Sell
39,349
-369
-0.9% -$1.75K 0.06% 92
2018
Q1
$170K Buy
+39,718
New +$188K 0.06% 85

Other funds holding ASPN

Gagnon Securities's ASPN Position: Q2 2026 in Review

Gagnon Securities reduced its Aspen Aerogels (ASPN) stake by 18% in Q2 2026, selling an estimated $1.6M and leaving 1,535,812 shares worth $9.74M. The position accounts for 1.88% of the portfolio, ranked #22.

Gagnon Securities first reported a position in ASPN in Q1 2018 and has held it in 8 quarters since. The position peaked at $12.2M in Q3 2025. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Gagnon Securities held 1,535,812 shares of Aspen Aerogels worth $9.74M as of Q2 2026.
  • Gagnon Securities sold 326,039 Aspen Aerogels shares in Q2 2026, an estimated $1.6M.
  • Aspen Aerogels made up 1.88% of Gagnon Securities's portfolio in Q2 2026, its #22 holding.
  • Gagnon Securities first reported a position in Aspen Aerogels in Q1 2018 and has held it in 8 quarters since.
  • Gagnon Securities's Aspen Aerogels position peaked at $12.2M in Q3 2025.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Gagnon Securities's 13F filing for Q2 2026, filed 5 Aug 2026.